Koen Rijs1, Markus Klimek1, Marjan Scheltens-de Boer2, Karla Biesheuvel2, Biswadjiet S Harhangi3. 1. Department of Anesthesiology, Erasmus University Medical Centre, Rotterdam, The Netherlands. 2. Department of Clinical Neurophysiology, Erasmus University Medical Centre, Rotterdam, The Netherlands. 3. Department of Neurosurgery, Erasmus University Medical Centre, Rotterdam, The Netherlands. Electronic address: b.s.harhangi@erasmusmc.nl.
Abstract
BACKGROUND: Intramedullary spinal cord tumors (IMSCT) comprise the least common types of spinal neoplasms; surgery is mostly conducted with intraoperative neuromonitoring (IONM). However, although IONM is widely used to prevent neurologic damage and many single-center studies have been reported, the added value, in terms of overall sensitivity and specificity, of different monitoring techniques used in IMSCT surgery remains to be clearly defined. OBJECTIVE: To summarize and review the reported evidence on the use of IONM in IMSCT surgery, including our own case series (n = 75 patients). METHODS: We systematically searched the literature published from January 2000 to February 2018. Articles included patients with IMSCT who underwent surgery with neuromonitoring. We estimated the sensitivity, specificity, 95% confidence interval (CI), positive likelihood ratio, and negative likelihood ratio. RESULTS: Of 1385 eligible articles, 31 were included in the systematic review. Fifteen of these articles were used for a meta-analysis, complemented with our own case series. All neuromonitoring modalities showed acceptable but not optimal test characteristics. For the indications used in the different studies, the motor evoked potentials approach showed the highest sensitivity (0.838; 95% CI, 0.703-0.919) and the best specificity (0.829; 95% CI, 0.668-0.921) for detecting neuronal injury. In our own case series, the extent of resection was significantly smaller in the false-positive group than in the true-negative group (P = 0.045). CONCLUSIONS: IONM showed high but not perfect sensitivity and specificity. IONM prevents neurologic damage but can also limit the extent of tumor resection. Prospective studies will have to define the definitive value of IONM.
BACKGROUND: Intramedullary spinal cord tumors (IMSCT) comprise the least common types of spinal neoplasms; surgery is mostly conducted with intraoperative neuromonitoring (IONM). However, although IONM is widely used to prevent neurologic damage and many single-center studies have been reported, the added value, in terms of overall sensitivity and specificity, of different monitoring techniques used in IMSCT surgery remains to be clearly defined. OBJECTIVE: To summarize and review the reported evidence on the use of IONM in IMSCT surgery, including our own case series (n = 75 patients). METHODS: We systematically searched the literature published from January 2000 to February 2018. Articles included patients with IMSCT who underwent surgery with neuromonitoring. We estimated the sensitivity, specificity, 95% confidence interval (CI), positive likelihood ratio, and negative likelihood ratio. RESULTS: Of 1385 eligible articles, 31 were included in the systematic review. Fifteen of these articles were used for a meta-analysis, complemented with our own case series. All neuromonitoring modalities showed acceptable but not optimal test characteristics. For the indications used in the different studies, the motor evoked potentials approach showed the highest sensitivity (0.838; 95% CI, 0.703-0.919) and the best specificity (0.829; 95% CI, 0.668-0.921) for detecting neuronal injury. In our own case series, the extent of resection was significantly smaller in the false-positive group than in the true-negative group (P = 0.045). CONCLUSIONS: IONM showed high but not perfect sensitivity and specificity. IONM prevents neurologic damage but can also limit the extent of tumor resection. Prospective studies will have to define the definitive value of IONM.
Authors: Semih Kivanc Olguner; Ali Arslan; Vedat Açık; İsmail İstemen; Mehmet Can; Yurdal Gezercan; Ali İhsan Ökten Journal: Front Oncol Date: 2021-01-28 Impact factor: 6.244
Authors: Wai C Soon; Benjamin Fisher; Yasir A Chowdhury; James Hodson; Edward Fashola; Ofuchi Egbuji; Andraay Leung; Marcin Czyz; Navin Furtado; Jasmeet Dhir Journal: Cureus Date: 2022-02-01
Authors: Grégoire P Chatain; Michael W Kortz; Stephanie Serva; Keshari Shrestha; Patrick Hosokawa; Timothy H Ung; Michael Finn Journal: Neurospine Date: 2022-03-31
Authors: Zachary T Olmsted; Brendan Ryu; Ganesh Phayal; Ross Green; Sheng-Fu Larry Lo; Daniel M Sciubba; Justin W Silverstein; Randy S D'Amico Journal: World Neurosurg X Date: 2022-09-15